Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897922 · ClinicalTrials.gov registry record · NA
The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants
A NA study of Growth of Term Infants, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 348
- Enrollment target
- 20
- Study locations
NCT01897922: Completed NA study of Growth of Term Infants, sponsored by Mead Johnson Nutrition.
NCT01897922 is a NA study of Growth of Term Infants that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 348 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897922, a NA study of Growth of Term Infants, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial will evaluate an investigational infant formula with a probiotic to determine if it provides normal growth and if it is well tolerated by term infants compared to a marketed routine infant formula.
Conditions Studied
Interventions
- OTHER An investigational infant formula containing a probiotic source
- OTHER Control: Marketed routine infant formula
Study Locations (20)
Alabama
- Birmingham Pediatric Associates - Birmingham
- Greenvale Pediatrics Hoover - Birmingham
- Southeastern Pediatric Associates - Dothan
- Pediatrics East - Alabama Clinical Therapeutics - Pinson
Ohio
- Pediatric Associates of Mt. Carmel, Inc - Cincinnati
- Pediatric Associates of Fairfield, Inc. - Fairfield
- Parma Pediatrics, Inc - Parma
- UHMP Comprehensive Pediatrics - Westlake
Arkansas
- The Children's Clinic of Jonesboro, P.A. - Jonesboro
- Arkkansas Pediatric Clinic - Little Rock
Florida
- Children's Research, LLC - Altamonte Springs
- Children's Medical Associations - Plantation
North Carolina
- Cary Pediatric Center, P.A. - Cary
- Capital Pediatrics & Adolescent Center - Raleigh
Tennessee
- The Jackson Clinic - North Jackson - Jackson
- Holston Medical Group - Kingsport
Connecticut
- Norwich Pediatric Group, P.C. - Norwich
Indiana
- Deaconess Clinical Research - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01897922 record still lists
NCT01897922 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Growth of Term Infants appearing as the primary indexed condition, and to 2 interventions - of which An investigational infant formula containing a probiotic source is the first listed.
NCT01897922 names 20 study sites across 10 states, led by Alabama, Ohio, Arkansas.
Frequently Asked Questions
What is clinical trial NCT01897922 about?
NCT01897922 is a clinical study titled "The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants". This clinical trial will evaluate an investigational infant formula with a probiotic to determine if it provides normal growth and if it is well tolerated by term infants compared to a marketed routine infant formula.
What is the current status of trial NCT01897922?
This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2013-07. Estimated completion is 2014-04.
What conditions does trial NCT01897922 study?
This clinical trial studies the following conditions: Growth of Term Infants.
What interventions are being tested in trial NCT01897922?
The interventions under investigation include: An investigational infant formula containing a probiotic source (OTHER), Control: Marketed routine infant formula (OTHER).
Who is sponsoring clinical trial NCT01897922?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01897922 being conducted?
This trial has 20 study locations across Alabama, Arkansas, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01897922's enrollment target sits among peer trials
348 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia